Ex vivo detection of iron oxide magnetic nanoparticles in mice using their intrinsic peroxidase-mimicking activity.

Iron oxide magnetic nanoparticles (MNPs) are widely used as diagnostic and therapeutic agents for biomedical applications. Quantitatively analyzing biodistribution, pharmacokinetics and organ clearance of MNPs in mouse models is important for understanding their in vivo behavior. In this study, we developed a novel histochemical method for visualizing unlabeled MNPs in mouse tissues by employing their intrinsic peroxidase-mimicking activity, regarding which we reported previously that MNPs could catalyze the oxidation of peroxidase substrates to produce a color reaction at the site of MNPs (Gao et al. Nat. Nanotechnol.2007, 2, 577-583). Based on this MNPs-peroxidase approach, we determined the biodistribution and organ clearance of MNPs by visualizing and quantifying the localization of MNPs within the main organs. Compared to traditional Prussian blue assay, this novel MNPs-peroxidase approach has higher sensitivity. In conclusion, the developed MNPs-peroxidase approach based on intrinsic peroxidase activity of iron oxide nanoparticles was used effectively for quantitative detection of MNPs in mice by histochemical staining. Presumably, other nanoparticles having intrinsic peroxidase activity could also be considered.

[1]  Ana C. A. Roque,et al.  A biotechnological perspective on the application of iron oxide magnetic colloids modified with polysaccharides. , 2011, Biotechnology advances.

[2]  J. Dobson.  Magnetic nanoparticles for drug delivery , 2006 .

[3]  Raoul Kopelman,et al.  Synthesis and characterization of silica-embedded iron oxide nanoparticles for magnetic resonance imaging. , 2004, Journal of nanoscience and nanotechnology.

[4]  Mathias Hoehn,et al.  Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia , 2004, Magnetic resonance in medicine.

[5]  María Vallet-Regí,et al.  Mesoporous Materials for Drug Delivery , 2008 .

[6]  Ajay Kumar Gupta,et al.  Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. , 2007, Nanomedicine.

[7]  S. Dong,et al.  Ordered magnetic core-manganese oxide shell nanostructures and their application in water treatment , 2009 .

[8]  Hak Soo Choi,et al.  Design considerations for tumour-targeted nanoparticles. , 2010, Nature nanotechnology.

[9]  P. Morais,et al.  Magnetic resonance of a dextran-coated magnetic fluid intravenously administered in mice. , 2001, Biophysical journal.

[10]  Yu Zhang,et al.  Fluorescence Modified Chitosan-Coated Magnetic Nanoparticles for High-Efficient Cellular Imaging , 2009, Nanoscale research letters.

[11]  Qing Peng,et al.  Monodisperse magnetic single-crystal ferrite microspheres. , 2005, Angewandte Chemie.

[12]  María Vallet-Regí,et al.  Mesoporous materials for drug delivery. , 2007, Angewandte Chemie.

[13]  Maiyong Zhu,et al.  Synthesis of Porous Fe3O4 Nanospheres and Its Application for the Catalytic Degradation of Xylenol Orange , 2011 .

[14]  Tsuneji Nagai,et al.  Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. , 2008, International journal of pharmaceutics.

[15]  Xiaogang Qu,et al.  Graphene Oxide: Intrinsic Peroxidase Catalytic Activity and Its Application to Glucose Detection , 2010, Advanced materials.

[16]  Indrajit Roy,et al.  Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. , 2008, ACS nano.

[17]  S. Tonegawa,et al.  Heme oxygenase 1 is required for mammalian iron reutilization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Babeş,et al.  Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study. , 1999, Journal of colloid and interface science.

[19]  Yu Zhang,et al.  Decomposing phenol by the hidden talent of ferromagnetic nanoparticles. , 2008, Chemosphere.

[20]  Yu Chen,et al.  Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands , 2011 .

[21]  Sander R. Dubovy,et al.  Evaluation of Magnetic Micro- and Nanoparticle Toxicity to Ocular Tissues , 2011, PloS one.

[22]  C. Galbán,et al.  Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. , 2011, Biomaterials.

[23]  Michael J. Welch,et al.  In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. , 2010, Bioconjugate chemistry.

[24]  Yu Zhang,et al.  Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. , 2007, Nature nanotechnology.

[25]  D. S. Letbetter,et al.  Surface-immobilized dextran limits cell adhesion and spreading. , 2000, Biomaterials.

[26]  Erkang Wang,et al.  Fe3O4 magnetic nanoparticles as peroxidase mimetics and their applications in H2O2 and glucose detection. , 2008, Analytical chemistry.

[27]  Andrea Protti,et al.  Synthesis of 64CuII–Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In Vivo Evaluation as Dual-Modality PET–MRI Agent** , 2011, Angewandte Chemie.

[28]  T. Yen,et al.  The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. , 2010, Biomaterials.

[29]  D. Leslie-Pelecky,et al.  Iron oxide nanoparticles for sustained delivery of anticancer agents. , 2005, Molecular pharmaceutics.

[30]  Greg M Thurber,et al.  18F labeled nanoparticles for in vivo PET-CT imaging. , 2009, Bioconjugate chemistry.

[31]  D. Rubin,et al.  Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. , 1997, Radiology.

[32]  Lihua Zhu,et al.  Efficient removal of organic pollutants with magnetic Nanoscaled BiFeO(3) as a reusable heterogeneous fenton-like catalyst. , 2010, Environmental science & technology.

[33]  É. Duguet,et al.  Magnetic nanoparticle design for medical diagnosis and therapy , 2004 .

[34]  K. Nguyen,et al.  Autonomic Denervation With Magnetic Nanoparticles , 2010, Circulation.

[35]  H. H. Yiu,et al.  Engineering the multifunctional surface on magnetic nanoparticles for targeted biomedical applications: a chemical approach. , 2011, Nanomedicine.